Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Epilepsy Behav. 2020 Jan 27;104(Pt A):106907. doi: 10.1016/j.yebeh.2020.106907

Table 3:

Demographic and Mental Health Treatment Characteristics by Symptom Screen Type

All Subjects (N=199) Anxiety positive only (N=71) Depression positive only (N=45) Anxiety & depression positive (N=83) P-value*
Age (yrs) (mean SD) 42.9 ± 15.5 41.4 ± 15.4 44.8 ± 13.7 43.2 ± 16.4 0.50
Female 114 (57.3%) 45 (63.4%) 24 (53.3%) 45 (54.2%) 0.43
Race 0.40
 White or Caucasian 169 (84.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
 Black or African American 24 (12.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
 Other 6 (3.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Hispanic/Latino 6 (3.0%) 5 (7.0%) 0 (0.0%) 1 (1.2%) 0.04
Opt-in to research 154 (77.4%) 49 (69.0%) 34 (75.6%) 71 (85.5%) 0.05
Currently on antidepressant medication?** 87 (43.7%) 25 (35.2%) 18 (40.0%) 44 (53.0%) 0.07
Current treatment by psychiatrist or therapist? 61 (30.7%) 11 (15.5%) 13 (28.9%) 37 (44.6%) <0.001
Prior psychiatric hospitalization 48 (24.1%) 14 (19.7%) 12 (26.7%) 22 (26.5%) 0.56
*

chi square test; chi square p value shown at top of category label for categorical variables having more than 2 categories

**

SSRI, SNRI, mirtazapine, bupropion, or buspirone